Kiran Kaur Sethi, the celebrity skin doctor who runs New Delhis Isya Aesthetics, said of the drugs
As demand for these medications has grown, many plans are using utilization management strategies, including: Prior authorization Step therapy Formulary exclusions Higher BMI eligibility thresholds Requirements for multiple obesity-related comorbidities Mandatory lifestyle programs At the same time, access is becoming more complex
Guevara-Aguirre J
Circulation 139:e1046e1081
Obesity + T2D cohort, 52 weeks: Additional findings: No association with bone mineral density changes GI side effects (nausea, vomiting, constipation) were the most common but predominantly mild, transient, primarily associated with the first dose, and substantially reduced with dose escalation Retatrutide: Phase 3 Reference Data The Direct Mechanism Comparison Why the Weight Loss Numbers Are Not Directly Comparable The most common mistake in covering these two drugs is placing their weight loss figures side by side without acknowledging the evidence gap
In contrast, only lanifibranor promoted fibrosis regression as indicated by quantitative histology
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
